Carregant...
Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Children Aged Less than 15 Years in Guinea-Bissau – An Open-Label Non-Inferiority Randomised Clinical Trial
BACKGROUND: Artemether-lumefantrine (AL) was introduced for treatment of uncomplicated malaria in Guinea-Bissau in 2008. Malaria then resurged and recurrent malaria after treatment with AL and stock-outs of AL were common. This study therefore aimed to assess the efficacy of AL and identify an alter...
Guardat en:
Publicat a: | PLoS One |
---|---|
Autors principals: | , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Public Library of Science
2016
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5030079/ https://ncbi.nlm.nih.gov/pubmed/27649561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0161495 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|